Medicare Seeks To Limit Coverage For Controversial Alzheimer’s Drug Aduhelm

Topline The Centers for Medicare and Medicaid Services proposed limiting coverage for Alzheimer’s drug Aduhelm to patients participating in clinical trials Tuesday, after many medical experts claimed ...